Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Sheryl L Conley is Director at Anika Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jun 23, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
Sheryl L Conley has no open-market purchase on record since 2021. Sales in 1 of the 6 years since 2021.
Sheryl L Conley reported 0 open-market purchases and 2 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2021 | — | $181K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Sheryl L Conley reported 0 open-market purchases and 2 sales here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Jun 18, 202610Kdisclosed Jun 23
DetailsOfficial recordNeuroneticsSTIM
May 28, 202630Kdisclosed May 29
DetailsOfficial recordAs of the latest filing on , Sheryl L Conley reported holding 52,970 shares of Anika Therapeutics (ANIK), worth about $710K at the last close of $13 (Nov 13, 2026). Holdings are also on file at Neuronetics (STIM); together they are worth about $1.06M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Anika Therapeutics ANIK | 52,970 | 53K direct | $13 | $710K | Jun 18, 2026 |
| Neuronetics STIM | 251,716 | 252K direct | $1 | $350K | May 28, 2026 |
Is this Sheryl L Conley’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jun 18, 2026, Sheryl L Conley reported holding 52,970 shares of Anika Therapeutics (ANIK). At the last close of $13 on Nov 13, 2026, that is about $710K. This is the stake disclosed in filings, not a net worth.
Sheryl L Conley has no open-market purchase on record since 2021. Sales in 1 of the 6 years since 2021.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2021.
Neuronetics (STIM), from 2021 to 2021: 0 purchases and 2 sales.
